Med BioGene Records $594K in H1 2011 Revenues | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic test development firm Med BioGene today reported revenues of $593,714 for the first half of 2011, compared to no revenues in the year-ago period.

All revenues during the six months ended June 30 were generated from licensing deals.

For the half-year, the Vancouver, British Columbia-based firm posted net income of $215,034, or break-even on an EPS basis, compared to a loss of $1 million, or $.01 per share, for the first half of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.